Effects of Dry Needling Technique in Hip Muscles in Subjects With Grade I-III Hip Osteoarthritis

Hip Osteoarthritis Clinical Trial

Official title:

Effects of Dry Needling Technique in Hip Muscles in Subjects With Grade I-III Hip Osteoarthritis

Clinical Trial Details — Status: Active, not recruiting

Administrative data

• NCT number: NCT03202056
• Other study ID #: C.I.PI17/0182
• Status: Active, not recruiting
• Phase: N/A
• Start date: January 1, 2018
• Est. completion date: January 2019

Study information

• Verified date: October 2018
• Source: Universidad de Zaragoza
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Dry needling is a new treatment technique, addressed to mechanical pain of the neuromusculoskeletal system. Recent investigations has developed new hypothesis about the etiology of the osteoarthritis and could be in relation to musculoskeletal disorders, but there is no published studies evaluating the results of this technique in hip osteoarthritis patients.

The objective of this trial is to evaluate if dry needling is more effective in symptoms, function, range of motion, strength, muscular length, pain threshold and compared to sham dry needling and control.

For this purpose the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of hip osteoarthritis Grade I-III by Scale of Kellgren and Lawrence.

Patients included are randomized into 3 groups one receive Dry needling, other sham dry needling and the other is a control. Groups receive 3 treatment sessions.

The variables are measured at the beginning and end of treatment. And also some variables are measured before and after each session. Patients who participated in sham dry needling or control group, when the intervention finish the investigators will be given the opportunity to receive the actual technique.

Recruitment information / eligibility

• Status: Active, not recruiting
• Enrollment: 45
• Est. completion date: January 2019
• Est. primary completion date: November 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 50 Years to 70 Years

Eligibility

Inclusion Criteria:

• Diagnosed medically with a X-Ray test

• American College of Rheumatology Criteria

Exclusion Criteria:

• Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.

• Vascular or neurological disease.

• Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs

• Grade IV in Kellgren and Laurence Scale

• Fear of needles

Related Conditions & MeSH terms

• Hip Osteoarthritis
• Osteoarthritis
• Osteoarthritis, Hip

Intervention

Other:
• Dry needling
Dry needling is a skilled intervention that uses a thin filiform needle to penetrate the skin and stimulate underlying myofascial trigger points, muscular, and connective tissues for the management of neuromusculoskeletal pain and movement impairments.
• Sham Dry needling
Sham Dry needling use a non-penetrating acupuncture needle

Locations

Country	Name	City	State
Spain	Luis Ceballos Laita	Zaragoza

Sponsors (1)

Lead Sponsor	Collaborator
Universidad de Zaragoza

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Functional Capacity with functional tests	The investigators measure the functional capacity with functional test: "test Up and Go" (TUG), "20 and 40 meters self-placed" and "30 seconds-chair stand" at baseline	Baseline
Primary	Intensity symptoms	The investigators measure the intensity of with a visual analogic scale pre-intervention at baseline	Baseline
Primary	Intensity symptoms	The investigators measure the intensity of with a visual analogic scale at the end of the intervention (3 weeks after baseline the investigators measure the intensity of symptoms through study completion, an average 21 days)	through study completion, an average 21 days
Primary	Functional Capacity with functional tests	The investigator measure the functional capacity with functional test: "Test Up and Go" (TUG test), "20 and 40 meters self-placed" and "30 seconds-chair and stand" at the end of the intervention (through study completion, an average 21 days).	through study completion, an average 21 days
Secondary	Hip Range of motion	The investigators measure the hip range of motion with an inclinometer at baseline	Baseline
Secondary	Hip Range of motion	The investigators measure the hip range of motion with an inclinometer at the end of the intervention (through study completion, an average 21 days)	through study completion, an average 21 days
Secondary	Muscular strength	The investigators measure the hip strength with a hand held dynamometer (Lafayette) at baseline	Baseline
Secondary	Muscular strength	The investigators measure the hip strength with a hand held dynamometer (Lafayette) at the end of the intervention (through study completion, an average 21 days)	through study completion, an average 21 days
Secondary	Muscular length	The investigators measure the muscular length with Passive Knee Extension test, ELY test, and modified Ober test at baseline	Baseline
Secondary	Muscular length	The investigators measure the muscular length with Passive Knee Extension test, ELY test, and modified Ober test at the end of the intervention (through study completion, an average 21 days)	through study completion, an average 21 days
Secondary	Pain threshold	The investigators measure the pain threshold with a digital algometer in myofascial trigger points of the hip muscles, and also other bone areas to discriminate a central sensitization at baseline	Baseline
Secondary	Pain threshold	The investigators measure the pain threshold with a digital algometer in myofascial trigger points of the hip muscles, and also other bone areas to discriminate a central sensitization at the end of the intervention (through study completion, an average 21 days)	through study completion, an average 21 days
Secondary	Anxiety and depression with a validated questionnaire (HADS)	The investigators measure the anxiety and depression with HADS questionnaire at baseline	Baseline
Secondary	Anxiety and depression with a validated questionnaire (HADS)	The investigators measure the anxiety and depression with HADS questionnaire at the end of the intervention (through study completion, an average 21 days)	through study completion, an average 21 days
Secondary	Functional capacity with a validated questionnaire (WOMAC)	The investigator measure the functional capacity with WOMAC questionnaire at baseline	Baseline
Secondary	Functional capacity with a validated questionnaire (WOMAC)	The investigator measure the functional capacity with WOMAC questionnaire at the end of the intervention (through study completion, an average 21 days)	through study completion, an average 21 days
Secondary	Gait in treadmill	The investigator measure gait pattern in treadmill using wearable inertial sensors to track body kinematics during gait	Baseline
Secondary	Gait in treadmill	The investigator measure gait pattern in treadmill using wearable inertial sensors to track body kinematics during gait	through study completion